Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

RxSight (RXST) Operating Expenses (2020 - 2025)

RxSight (RXST) has disclosed Operating Expenses for 6 consecutive years, with $36.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Expenses fell 2.18% year-over-year to $36.6 million, compared with a TTM value of $151.2 million through Dec 2025, up 11.34%, and an annual FY2025 reading of $151.2 million, up 11.34% over the prior year.
  • Operating Expenses was $36.6 million for Q4 2025 at RxSight, up from $36.4 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $39.2 million in Q2 2025 and bottomed at $12.3 million in Q1 2021.
  • Average Operating Expenses over 5 years is $26.6 million, with a median of $25.9 million recorded in 2023.
  • The sharpest move saw Operating Expenses surged 81.08% in 2021, then dropped 2.18% in 2025.
  • Year by year, Operating Expenses stood at $17.5 million in 2021, then rose by 27.83% to $22.4 million in 2022, then rose by 27.19% to $28.5 million in 2023, then surged by 31.26% to $37.4 million in 2024, then fell by 2.18% to $36.6 million in 2025.
  • Business Quant data shows Operating Expenses for RXST at $36.6 million in Q4 2025, $36.4 million in Q3 2025, and $39.2 million in Q2 2025.